Abstract
Berberis aristata, a revered medicinal shrub in traditional systems like Ayurveda, holds promise in managing diabetes mellitus, a burgeoning global health concern. Through a comprehensive analysis of its bioactive compounds and their interactions with potential targets, this study elucidates the molecular mechanisms underlying its anti-diabetic effects. Screening through databases yielded 17 bioactive compounds, including rutin, quercetin, and berberine. Protein-protein interaction analysis identified 44 potential targets, with 36 genes overlapping with disease-related genes, indicating pivotal pathways in diabetes mellitus treatment. Further, pathway analysis highlighted G-protein coupled receptor signaling, calcium signaling, and neurotransmitter receptor activity as significant, with adjusted p-values. Network analysis revealed key hub genes like DRD1 and MMP2, emphasizing their central role in Berberis aristata’s therapeutic action. The findings underscore Berberis aristata’s potential as a source of novel anti-diabetic agents and offer groundwork for potential research in this field.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: INTERNATIONAL JOURNAL OF PHARMACEUTICAL QUALITY ASSURANCE
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
